Charles J Lacey

Author PubWeight™ 16.06^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Global burden of human papillomavirus and related diseases.	Vaccine	2012	5.48
2	PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.	Lancet	2010	3.90
3	Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study.	BMJ	2012	1.19
4	Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease.	Medicine (Baltimore)	2005	1.11
5	Therapy of human papillomavirus-related disease.	Vaccine	2012	1.11
6	Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings.	J Clin Microbiol	2009	1.10
7	Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally.	PLoS One	2011	1.10
8	A randomized controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda.	AIDS	2005	0.84
9	Dextrin sulfate as a vaginal microbicide: randomized, double-blind, placebo-controlled trial including healthy female volunteers and their male partners.	J Acquir Immune Defic Syndr	2002	0.81